{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:22Z","timestamp":1788307762771,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Measles is a vaccine-preventable illness. Nevertheless, in recent years, measles is still endemic and epidemic in both the developed world and the developing world. The public perception of measles in the past was that it was not a big deal. However, measles is associated with a number of complications which can be places in three categories which are: acute(diarrhea, otitis media, pneumonia, encephalitis, seizures, and death) and delayed-subacute sclerosing panencephalitis (SSPE) and post-measles immune amnesia. Contrary to the beliefs of the anti-vaccine lobby, measles is bad. In acute measles, the death rate is 1\u20133 per 1000 and the risk of encephalitis is 1 per 1000. Relatively recent investigations indicate that SSPE is considerably more common than previously believed. The worldwide contribution of post-measles immune amnesia to morbidity and mortality is likely to be huge. In exposure situations, two doses of measles vaccine will prevent 99% of cases. Presently in the United States, the first dose is given at 12 through 15 months of age. The second dose is most often administered at 4 through 6 years of age. In my opinion, the second dose of measles vaccine should be given 4\u20136 weeks after the first dose rather than at 4\u20136 years of age. Children who don\u2019t have antibody to measles should not travel to risk areas.<\/jats:p>","DOI":"10.1093\/jpids\/piae018","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T20:09:32Z","timestamp":1709237372000},"page":"233-236","source":"Crossref","is-referenced-by-count":14,"title":["Ongoing Measles in the Developed and Developing World"],"prefix":"10.1093","volume":"13","author":[{"given":"James D","family":"Cherry","sequence":"first","affiliation":[{"name":"Pediatric Infectious Diseases, David Geffen School of Medicine at UCLA, Mattel Children\u2019s Hospital UCLA , Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"2024042405315396500_CIT0001","first-page":"1754","article-title":"Measles virus","volume-title":"Feigin and Cherry\u2019s Textbook of Pediatric Infectious Diseases","author":"Cherry","year":"2019","edition":"7"},{"key":"2024042405315396500_CIT0002","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2023.25527","article-title":"Despite safe and effective vaccine, measles cases and deaths increased worldwide from 2021 to 2022","volume":"331","author":"Rubin","year":"2024","journal-title":"JAMA"},{"key":"2024042405315396500_CIT0003","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000441-195409000-00013","article-title":"Modern measles","volume":"228","author":"Babbott","year":"1954","journal-title":"Am J Med Sci"},{"key":"2024042405315396500_CIT0004","first-page":"219","article-title":"Measles as a universal disease","volume":"103","author":"Wilson","year":"1962","journal-title":"Am J Dis Child"},{"key":"2024042405315396500_CIT0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1073\/pnas.27.1.7","article-title":"Contact and measles","volume":"27","author":"Wilson","year":"1941","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024042405315396500_CIT0006","first-page":"531","article-title":"Early measles epidemic in America","volume":"15","author":"Caulfield","year":"1943","journal-title":"Yale J Biol Med"},{"key":"2024042405315396500_CIT0007","first-page":"829","article-title":"Observations made during the epidemic of measles on the Faroe Islands in the year 1846","volume":"3","author":"Panum","year":"1939","journal-title":"Med Class"},{"key":"2024042405315396500_CIT0008","first-page":"918","article-title":"The diagnosis of the invasion of measles from a study of the exanthema as it appears on the buccal mucous membrane","volume":"13","author":"Koplik","year":"1896","journal-title":"Arch Pediatr"},{"key":"2024042405315396500_CIT0009","first-page":"505","article-title":"A new diagnostic sign of measles","volume":"53","author":"Koplik","year":"1898","journal-title":"Med Rec"},{"key":"2024042405315396500_CIT0010","first-page":"673","article-title":"The new diagnostic spots of measles on the buccal and labial mucous membrane","volume":"74","author":"Koplik","year":"1899","journal-title":"Med News"},{"key":"2024042405315396500_CIT0011","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3181\/00379727-86-21073","article-title":"Propagation in tissue cultures of cytopathogenic agents from patients with measles","volume":"86","author":"Enders","year":"1958","journal-title":"Proc Soc Exp Biol Med"},{"key":"2024042405315396500_CIT0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3181\/00379727-97-23637","article-title":"Propagation of measles virus in cultures of chick embryo cells","volume":"97","author":"Katz","year":"1958","journal-title":"Proc Soc Exp Biol Med"},{"key":"2024042405315396500_CIT0013","author":"Centers for Disease Control and Prevention"},{"key":"2024042405315396500_CIT0014","author":"Los Angeles County Health Alert Network"},{"key":"2024042405315396500_CIT0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archpedi.1962.02080020365035","article-title":"Studies with live attenuated measles-virus vaccine. Comparative clinical, antigenic, and prophylactic effects after inoculation with and without gamma-globulin","volume":"103","author":"Krugman","year":"1962","journal-title":"Am J Dis Child"},{"key":"2024042405315396500_CIT0016","author":"Centers for Disease Control and Prevention"},{"key":"2024042405315396500_CIT0017","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cid\/cix302","article-title":"Subacute sclerosing panencephalitis: the devastating measles complication that might be more common than previously estimated","volume":"65","author":"Wendorf","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2024042405315396500_CIT0018","doi-asserted-by":"crossref","first-page":"e68909","DOI":"10.1371\/journal.pone.0068909","article-title":"Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation","volume":"8","author":"Schonberger","year":"2013","journal-title":"PLoS One"},{"key":"2024042405315396500_CIT0019","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/adc.2003.038489","article-title":"The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990\u20132002","volume":"89","author":"Miller","year":"2004","journal-title":"Arch Dis Child"},{"key":"2024042405315396500_CIT0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.311.7003.481","article-title":"Non-specific beneficial effect of measles immunization: analysis of mortality studies from developing countries","volume":"311","author":"Aaby","year":"1995","journal-title":"BMJ"},{"key":"2024042405315396500_CIT0021","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.aaa3662","article-title":"Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality","volume":"348","author":"Mina","year":"2015","journal-title":"Science"},{"key":"2024042405315396500_CIT0022","first-page":"1","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"2024042405315396500_CIT0023","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.vaccine.2017.11.049","article-title":"Predictors of measles vaccination coverage among children 6\u201359 months of age in the Democratic Republic of the Congo","volume":"36","author":"Ashbaugh","year":"2018","journal-title":"Vaccine"},{"key":"2024042405315396500_CIT0024","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jpids\/piy099","article-title":"Association of previous measles infection with markers of acute infectious disease among 9- to 59-month-old children in the democratic Republic of the Congo","volume":"8","author":"Ashbaugh","year":"2019","journal-title":"J Pediatr Infect Dis Soc"},{"key":"2024042405315396500_CIT0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/INF.0000000000003840","article-title":"Reported history of measles and long-term impact on tetanus antibody detected in children 9\u201359 months of age and receiving 3 doses of tetanus vaccine in the democratic Republic of the Congo","volume":"42","author":"Ashbaugh","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"2024042405315396500_CIT0026","doi-asserted-by":"crossref","first-page":"e021465","DOI":"10.1136\/bmjopen-2017-021465","article-title":"Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK","volume":"8","author":"Gadroen","year":"2018","journal-title":"BMJ Open"},{"key":"2024042405315396500_CIT0027","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/INF.0000000000002599","article-title":"The susceptibility to other infectious diseases following measles during a three year observation period in Switzerland","volume":"39","author":"Behrens","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2024042405315396500_CIT0028","first-page":"503","volume-title":"Red Book: 2021 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2021"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piae018\/57074793\/piae018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/13\/4\/233\/57313904\/piae018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/13\/4\/233\/57313904\/piae018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T05:32:09Z","timestamp":1713936729000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/13\/4\/233\/7616563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2,29]]},"published-print":{"date-parts":[[2024,4,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piae018","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2024,2,29]]}}}